Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bioxytran's revenue for the twelve months ending Jun 30, 2018 was $177.80K, down 13.8% year over year. For fiscal 2017 it was $191.08K, down 22.5% from the year before. The highest annual figure on record is $417.34K in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $191.08K | -22.5% |
| FY2016 | Dec 31, 2016 | $246.50K | -3.6% |
| FY2015 | Dec 31, 2015 | $255.82K | -7.2% |
| FY2014 | Dec 31, 2014 | $275.62K | -34.0% |
| FY2013 | Dec 31, 2013 | $417.34K | +33.4% |
| FY2012 | Dec 31, 2012 | $312.90K | +310.1% |
| FY2011 | Dec 31, 2011 | $76.30K | +372.9% |
| FY2010 | Dec 31, 2010 | $16.13K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | $20.31K | -48.5% |
| Q1 FY2018 | Mar 31, 2018 | $13.32K | +79.1% |
| Q4 FY2017 | Dec 31, 2017 | $32.19K | -44.7% |
| Q3 FY2017 | Sep 30, 2017 | $111.98K | +10.7% |
| Q2 FY2017 | Jun 30, 2017 | $39.47K | – |
| Q1 FY2017 | Mar 31, 2017 | $7.44K | – |
| Q4 FY2016 | Dec 31, 2016 | $58.20K | – |
| Q3 FY2016 | Sep 30, 2016 | $101.14K | – |
See a number that looks wrong?